S 3129
116th Congress
Senate
Health
Administrative law and regulatory procedures
Advisory bodies
Business records
Civil actions and liability
Competitiveness, trade promotion, trade deficits
Congressional oversight
Consumer affairs
Executive agency funding and structure
Federal officials
Fraud offenses and financial crimes
Government employee pay, benefits, personnel management
Government information and archives
Health care costs and insurance
Health care coverage and access
Health information and medical records
Health personnel
Health programs administration and funding
Health technology, devices, supplies
Income tax deductions
Lower Costs, More Cures Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2019
Read twice and referred to the Committee on Finance.
Dec 19, 2019
Introduced in Senate
Plain-English summary
Lower Costs, More Cures Act of 2019
This bill establishes and modifies several requirements to address prescription drug prices under Medicare.
The bill generally
- limits payment amounts for drugs and biologics under Medicare medical services,
- reduces cost-sharing under the Medicare prescription drug benefit, and
- establishes several reporting requirements for drug manufacturers with respect to drug prices.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1